Liu S - Search Results

1

GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma.

Yan J, Zhou B, Guo L, Chen Z, Zhang B, Liu S, Zhang W, Yu M, Xu Y, Xiao Y, Zhou J, Fan J, Li H, Ye Q. Yan J, et al. Among authors: liu s. Am J Cancer Res. 2020 Nov 1;10(11):3705-3720. eCollection 2020. Am J Cancer Res. 2020. PMID: 33294262 Free PMC article.

2

Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma.

Zhou B, Guo L, Zhang B, Liu S, Zhang K, Yan J, Zhang W, Yu M, Chen Z, Xu Y, Xiao Y, Zhou J, Fan J, Li H, Ye Q. Zhou B, et al. Among authors: liu s. Am J Cancer Res. 2019 Nov 1;9(11):2442-2455. eCollection 2019. Am J Cancer Res. 2019. PMID: 31815045 Free PMC article.

3

Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma.

Zhou B, Yan J, Guo L, Zhang B, Liu S, Yu M, Chen Z, Zhang K, Zhang W, Li X, Xu Y, Xiao Y, Zhou J, Fan J, Hung MC, Li H, Ye Q. Zhou B, et al. Among authors: liu s. Theranostics. 2020 May 17;10(14):6530-6543. doi: 10.7150/thno.44417. eCollection 2020. Theranostics. 2020. PMID: 32483468 Free PMC article.

4

Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro.

Chen Z, Liu S, Xie P, Zhang B, Yu M, Yan J, Jin L, Zhang W, Zhou B, Li X, Xiao Y, Xu Y, Ye Q, Li H, Guo L. Chen Z, et al. Among authors: liu s. Biochem Biophys Res Commun. 2022 May 21;605:82-89. doi: 10.1016/j.bbrc.2022.03.075. Epub 2022 Mar 17. Biochem Biophys Res Commun. 2022. PMID: 35316767 Free article.

5

β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.

Li X, Lin Z, Zhang B, Guo L, Liu S, Li H, Zhang J, Ye Q. Li X, et al. Among authors: liu s. Sci Rep. 2016 Feb 12;6:21010. doi: 10.1038/srep21010. Sci Rep. 2016. PMID: 26867799 Free PMC article.

6

Longer duration of the Pringle maneuver is associated with hepatocellular carcinoma recurrence following curative resection.

Liu S, Li X, Li H, Guo L, Zhang B, Gong Z, Zhang J, Ye Q. Liu S, et al. J Surg Oncol. 2016 Jul;114(1):112-8. doi: 10.1002/jso.24271. Epub 2016 Apr 28. J Surg Oncol. 2016. PMID: 27122256

7

Is the Hong Kong Liver Cancer staging system the best guide for hepatitis B virus-related hepatocellular carcinoma patients with multiple tumors?

Liu S, Li X, Li H, Guo L, Zhang B, Zhang J, Ye Q. Liu S, et al. Oncotarget. 2016 Aug 9;7(32):51598-51607. doi: 10.18632/oncotarget.9956. Oncotarget. 2016. PMID: 27323396 Free PMC article.

8

Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1.

Li H, Li X, Liu S, Guo L, Zhang B, Zhang J, Ye Q. Li H, et al. Among authors: liu s. Hepatology. 2017 Dec;66(6):1920-1933. doi: 10.1002/hep.29360. Hepatology. 2017. PMID: 28732118

9

Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma.

Zhou C, Zhang W, Chen W, Yin Y, Atyah M, Liu S, Guo L, Shi Y, Ye Q, Dong Q, Ren N. Zhou C, et al. Among authors: liu s. Sci Rep. 2017 Sep 5;7(1):10570. doi: 10.1038/s41598-017-11029-y. Sci Rep. 2017. PMID: 28874807 Free PMC article.

10

Postoperative Adjuvant Trans-Arterial Chemoembolization for Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus.

Liu S, Guo L, Li H, Zhang B, Sun J, Zhou C, Zhou J, Fan J, Ye Q. Liu S, et al. Ann Surg Oncol. 2018 Jul;25(7):2098-2104. doi: 10.1245/s10434-018-6438-1. Epub 2018 May 4. Ann Surg Oncol. 2018. PMID: 29728879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78,042 results

Search Page

Filters